Updated: 05-Mar-26 09:09 ET
Co: MMED
MiniMed (Nasdaq) | Global diabetes technology company providing integrated insulin delivery and glucose monitoring solutions in more than 80 countries | Initial Shares: 28.0 M | Initial Range: $25.00-$28.00 | Priced On: NA | Opened: NA | Underwriters: Lead: Goldman Sachs & Co. LLC, BofA Securities, Citigroup and Morgan Stanley
There are no IPOs scheduled for this time period.
There are no IPOs scheduled for this time period.
There are no IPOs scheduled for this time period.